Register for our free email digests:
Latest From Asuragen Inc.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, Alliance, and Financing activity.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging biopharma, medtech, and diagnostic life science companies that have received venture funding.
- Antisense, Oligonucleotides
- Large Molecule
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Therapeutic Areas
- Infectious & Viral Diseases
- Respiratory, Pulmonary
- North America
- Parent & Subsidiaries
- Asuragen Inc.
- Senior Management
Matthew McManus, MD, PhD, Pres. & CEO
Lynne Hohlfeld, CFO
Matt Winkler, PhD, CSO
- Contact Info
Phone: (512) 681-5200
2150 Woodward St., Ste. 100
Austin, TX 78744
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.